Expansion Opportunities Checkpoint Surgical is actively expanding its intraoperative nerve care portfolio with products like CHECKPOINT GEMINI and Checkpoint Edge Nerve Cutting Kit, presenting upsell and cross-sell opportunities to surgical centers adopting advanced nerve stimulation and cutting tools.

Clinical Leadership With a leadership focus under new president and CEO Derek Lewis and a strong emphasis on surgeon collaboration, there is an opening to engage KOLs and hospital decision-makers to drive adoption of next-generation nerve stimulation devices and training programs.

Financial Momentum Recent financing activity totaling over forty million dollars and steady revenue in the mid-range position the company for scale; leverage this to approach hospitals and ambulatory surgery centers with modeled ROI and total cost of ownership for intraoperative nerve care solutions.

Product Lifecycle Existing product line spans nerve stimulators, nerve wraps, and cutting kits, creating cross-sell paths within neurosurgery, orthopedics, and peripheral nerve care teams across mid-market to larger institutions.

Tech & Readiness Adoption of modern tech and web stack including PWA readiness, Google Cloud, and SEO tools indicates a digitally capable organization; coordinate digital marketing and field marketing to reach procurement and clinical teams efficiently with product demos and training content.